🇺🇸 Pemetrexed + cisplatin in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 1 report (10%)
  2. Gait Inability — 1 report (10%)
  3. Hemiparesis — 1 report (10%)
  4. Malignant Neoplasm Progression — 1 report (10%)
  5. Metastases To Bone — 1 report (10%)
  6. Metastases To Central Nervous System — 1 report (10%)
  7. Metastases To Heart — 1 report (10%)
  8. Metastases To Liver — 1 report (10%)
  9. Metastases To Lung — 1 report (10%)
  10. Metastases To Pleura — 1 report (10%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Pemetrexed + cisplatin approved in United States?

Pemetrexed + cisplatin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Pemetrexed + cisplatin in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.